0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Mumps Virus Vaccine Live Market Research Report 2026
Published Date: 2026-02-09
|
Report Code: QYRE-Auto-37J18368
Home | Market Reports
Global Mumps Virus Vaccine Live Market Research Report 2024
BUY CHAPTERS

Global Mumps Virus Vaccine Live Market Research Report 2026

Code: QYRE-Auto-37J18368
Report
2026-02-09
Pages:90
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Mumps Virus Vaccine Live Market

The global Mumps Virus Vaccine Live market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Mumps Virus Vaccine Live competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
The mumps virus vaccine live is a live virus vaccine prepared using attenuated technology. It is used to prevent mumps, an acute respiratory infectious disease caused by the mumps virus. The virus contained in the vaccine has been weakened and will not cause disease, but can stimulate the body to produce immunity. After vaccination, it can effectively improve the resistance of children and adolescents to mumps and reduce the incidence rate. In my country, it is generally recommended that children aged 1-15 and adults who have not had mumps should be vaccinated with this vaccine.
The North American market for Mumps Virus Vaccine Live is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Mumps Virus Vaccine Live is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Mumps Virus Vaccine Live include Merck, GSK, SINOVAC, AIM Vaccine, Shanghai Institute of Biological Products, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Mumps Virus Vaccine Live market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Mumps Virus Vaccine Live. The Mumps Virus Vaccine Live market size, estimates, and forecasts are provided in terms of sales volume (KG) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Mumps Virus Vaccine Live market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Mumps Virus Vaccine Live manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Mumps Virus Vaccine Live Market Report

Report Metric Details
Report Name Mumps Virus Vaccine Live Market
Segment by Type
  • Single-dose Medication
  • Combination Medication
by Application
  • Children
  • Adults
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Merck, GSK, SINOVAC, AIM Vaccine, Shanghai Institute of Biological Products
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Mumps Virus Vaccine Live manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Mumps Virus Vaccine Live sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Mumps Virus Vaccine Live Market report?

Ans: The main players in the Mumps Virus Vaccine Live Market are Merck, GSK, SINOVAC, AIM Vaccine, Shanghai Institute of Biological Products

What are the Application segmentation covered in the Mumps Virus Vaccine Live Market report?

Ans: The Applications covered in the Mumps Virus Vaccine Live Market report are Children, Adults

What are the Type segmentation covered in the Mumps Virus Vaccine Live Market report?

Ans: The Types covered in the Mumps Virus Vaccine Live Market report are Single-dose Medication, Combination Medication

1 Mumps Virus Vaccine Live Market Overview
1.1 Product Definition
1.2 Mumps Virus Vaccine Live by Type
1.2.1 Global Mumps Virus Vaccine Live Market Value by Type: 2025 vs 2032
1.2.2 Single-dose Medication
1.2.3 Combination Medication
1.3 Mumps Virus Vaccine Live by Application
1.3.1 Global Mumps Virus Vaccine Live Market Value by Application: 2025 vs 2032
1.3.2 Children
1.3.3 Adults
1.4 Global Mumps Virus Vaccine Live Market Size Estimates and Forecasts
1.4.1 Global Mumps Virus Vaccine Live Revenue 2021–2032
1.4.2 Global Mumps Virus Vaccine Live Sales 2021–2032
1.4.3 Global Mumps Virus Vaccine Live Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Mumps Virus Vaccine Live Market Competition by Manufacturers
2.1 Global Mumps Virus Vaccine Live Sales Market Share by Manufacturers (2021–2026)
2.2 Global Mumps Virus Vaccine Live Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Mumps Virus Vaccine Live Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Mumps Virus Vaccine Live, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Mumps Virus Vaccine Live, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Mumps Virus Vaccine Live, Product Types and Applications
2.7 Global Key Manufacturers of Mumps Virus Vaccine Live, Date of Entry into the Industry
2.8 Global Mumps Virus Vaccine Live Market Competitive Situation and Trends
2.8.1 Global Mumps Virus Vaccine Live Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Mumps Virus Vaccine Live Players Market Share by Revenue
2.8.3 Global Mumps Virus Vaccine Live Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Mumps Virus Vaccine Live Market Scenario by Region
3.1 Global Mumps Virus Vaccine Live Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Mumps Virus Vaccine Live Sales by Region: 2021–2032
3.2.1 Global Mumps Virus Vaccine Live Sales by Region: 2021–2026
3.2.2 Global Mumps Virus Vaccine Live Sales by Region: 2027–2032
3.3 Global Mumps Virus Vaccine Live Revenue by Region: 2021–2032
3.3.1 Global Mumps Virus Vaccine Live Revenue by Region: 2021–2026
3.3.2 Global Mumps Virus Vaccine Live Revenue by Region: 2027–2032
3.4 North America Mumps Virus Vaccine Live Market Facts & Figures by Country
3.4.1 North America Mumps Virus Vaccine Live Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Mumps Virus Vaccine Live Sales by Country (2021–2032)
3.4.3 North America Mumps Virus Vaccine Live Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Mumps Virus Vaccine Live Market Facts & Figures by Country
3.5.1 Europe Mumps Virus Vaccine Live Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Mumps Virus Vaccine Live Sales by Country (2021–2032)
3.5.3 Europe Mumps Virus Vaccine Live Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Mumps Virus Vaccine Live Market Facts & Figures by Region
3.6.1 Asia Pacific Mumps Virus Vaccine Live Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Mumps Virus Vaccine Live Sales by Region (2021–2032)
3.6.3 Asia Pacific Mumps Virus Vaccine Live Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Mumps Virus Vaccine Live Market Facts & Figures by Country
3.7.1 Latin America Mumps Virus Vaccine Live Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Mumps Virus Vaccine Live Sales by Country (2021–2032)
3.7.3 Latin America Mumps Virus Vaccine Live Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Mumps Virus Vaccine Live Market Facts & Figures by Country
3.8.1 Middle East and Africa Mumps Virus Vaccine Live Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Mumps Virus Vaccine Live Sales by Country (2021–2032)
3.8.3 Middle East and Africa Mumps Virus Vaccine Live Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Mumps Virus Vaccine Live Sales by Type (2021–2032)
4.1.1 Global Mumps Virus Vaccine Live Sales by Type (2021–2026)
4.1.2 Global Mumps Virus Vaccine Live Sales by Type (2027–2032)
4.1.3 Global Mumps Virus Vaccine Live Sales Market Share by Type (2021–2032)
4.2 Global Mumps Virus Vaccine Live Revenue by Type (2021–2032)
4.2.1 Global Mumps Virus Vaccine Live Revenue by Type (2021–2026)
4.2.2 Global Mumps Virus Vaccine Live Revenue by Type (2027–2032)
4.2.3 Global Mumps Virus Vaccine Live Revenue Market Share by Type (2021–2032)
4.3 Global Mumps Virus Vaccine Live Price by Type (2021–2032)
5 Segment by Application
5.1 Global Mumps Virus Vaccine Live Sales by Application (2021–2032)
5.1.1 Global Mumps Virus Vaccine Live Sales by Application (2021–2026)
5.1.2 Global Mumps Virus Vaccine Live Sales by Application (2027–2032)
5.1.3 Global Mumps Virus Vaccine Live Sales Market Share by Application (2021–2032)
5.2 Global Mumps Virus Vaccine Live Revenue by Application (2021–2032)
5.2.1 Global Mumps Virus Vaccine Live Revenue by Application (2021–2026)
5.2.2 Global Mumps Virus Vaccine Live Revenue by Application (2027–2032)
5.2.3 Global Mumps Virus Vaccine Live Revenue Market Share by Application (2021–2032)
5.3 Global Mumps Virus Vaccine Live Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Mumps Virus Vaccine Live Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Merck Mumps Virus Vaccine Live Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 GSK
6.2.1 GSK Company Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Mumps Virus Vaccine Live Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 GSK Mumps Virus Vaccine Live Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 SINOVAC
6.3.1 SINOVAC Company Information
6.3.2 SINOVAC Description and Business Overview
6.3.3 SINOVAC Mumps Virus Vaccine Live Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 SINOVAC Mumps Virus Vaccine Live Product Portfolio
6.3.5 SINOVAC Recent Developments/Updates
6.4 AIM Vaccine
6.4.1 AIM Vaccine Company Information
6.4.2 AIM Vaccine Description and Business Overview
6.4.3 AIM Vaccine Mumps Virus Vaccine Live Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 AIM Vaccine Mumps Virus Vaccine Live Product Portfolio
6.4.5 AIM Vaccine Recent Developments/Updates
6.5 Shanghai Institute of Biological Products
6.5.1 Shanghai Institute of Biological Products Company Information
6.5.2 Shanghai Institute of Biological Products Description and Business Overview
6.5.3 Shanghai Institute of Biological Products Mumps Virus Vaccine Live Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Shanghai Institute of Biological Products Mumps Virus Vaccine Live Product Portfolio
6.5.5 Shanghai Institute of Biological Products Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Mumps Virus Vaccine Live Industry Chain Analysis
7.2 Mumps Virus Vaccine Live Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Mumps Virus Vaccine Live Production Mode & Process Analysis
7.4 Mumps Virus Vaccine Live Sales and Marketing
7.4.1 Mumps Virus Vaccine Live Sales Channels
7.4.2 Mumps Virus Vaccine Live Distributors
7.5 Mumps Virus Vaccine Live Customer Analysis
8 Mumps Virus Vaccine Live Market Dynamics
8.1 Mumps Virus Vaccine Live Industry Trends
8.2 Mumps Virus Vaccine Live Market Drivers
8.3 Mumps Virus Vaccine Live Market Challenges
8.4 Mumps Virus Vaccine Live Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Mumps Virus Vaccine Live Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Mumps Virus Vaccine Live Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Mumps Virus Vaccine Live Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Mumps Virus Vaccine Live Sales (KG) of Key Manufacturers (2021–2026)
 Table 5. Global Mumps Virus Vaccine Live Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Mumps Virus Vaccine Live Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Mumps Virus Vaccine Live Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Mumps Virus Vaccine Live Average Price (US$/G) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Mumps Virus Vaccine Live, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Mumps Virus Vaccine Live, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Mumps Virus Vaccine Live, Product Types and Applications
 Table 12. Global Key Manufacturers of Mumps Virus Vaccine Live, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Mumps Virus Vaccine Live Companies by Tier (Tier 1, Tier 2, Tier 3), based on Mumps Virus Vaccine Live Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Mumps Virus Vaccine Live Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Mumps Virus Vaccine Live Sales by Region (KG), 2021–2026
 Table 18. Global Mumps Virus Vaccine Live Sales Market Share by Region (2021–2026)
 Table 19. Global Mumps Virus Vaccine Live Sales by Region (KG), 2027–2032
 Table 20. Global Mumps Virus Vaccine Live Sales Market Share by Region (2027–2032)
 Table 21. Global Mumps Virus Vaccine Live Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Mumps Virus Vaccine Live Revenue Market Share by Region (2021–2026)
 Table 23. Global Mumps Virus Vaccine Live Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Mumps Virus Vaccine Live Revenue Market Share by Region (2027–2032)
 Table 25. North America Mumps Virus Vaccine Live Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Mumps Virus Vaccine Live Sales by Country (KG), 2021–2026
 Table 27. North America Mumps Virus Vaccine Live Sales by Country (KG), 2027–2032
 Table 28. North America Mumps Virus Vaccine Live Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Mumps Virus Vaccine Live Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Mumps Virus Vaccine Live Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Mumps Virus Vaccine Live Sales by Country (KG), 2021–2026
 Table 32. Europe Mumps Virus Vaccine Live Sales by Country (KG), 2027–2032
 Table 33. Europe Mumps Virus Vaccine Live Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Mumps Virus Vaccine Live Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Mumps Virus Vaccine Live Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Mumps Virus Vaccine Live Sales by Region (KG), 2021–2026
 Table 37. Asia Pacific Mumps Virus Vaccine Live Sales by Region (KG), 2027–2032
 Table 38. Asia Pacific Mumps Virus Vaccine Live Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Mumps Virus Vaccine Live Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Mumps Virus Vaccine Live Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Mumps Virus Vaccine Live Sales by Country (KG), 2021–2026
 Table 42. Latin America Mumps Virus Vaccine Live Sales by Country (KG), 2027–2032
 Table 43. Latin America Mumps Virus Vaccine Live Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Mumps Virus Vaccine Live Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Mumps Virus Vaccine Live Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Mumps Virus Vaccine Live Sales by Country (KG), 2021–2026
 Table 47. Middle East and Africa Mumps Virus Vaccine Live Sales by Country (KG), 2027–2032
 Table 48. Middle East and Africa Mumps Virus Vaccine Live Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Mumps Virus Vaccine Live Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Mumps Virus Vaccine Live Sales (KG) by Type (2021–2026)
 Table 51. Global Mumps Virus Vaccine Live Sales (KG) by Type (2027–2032)
 Table 52. Global Mumps Virus Vaccine Live Sales Market Share by Type (2021–2026)
 Table 53. Global Mumps Virus Vaccine Live Sales Market Share by Type (2027–2032)
 Table 54. Global Mumps Virus Vaccine Live Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Mumps Virus Vaccine Live Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Mumps Virus Vaccine Live Revenue Market Share by Type (2021–2026)
 Table 57. Global Mumps Virus Vaccine Live Revenue Market Share by Type (2027–2032)
 Table 58. Global Mumps Virus Vaccine Live Price (US$/G) by Type (2021–2026)
 Table 59. Global Mumps Virus Vaccine Live Price (US$/G) by Type (2027–2032)
 Table 60. Global Mumps Virus Vaccine Live Sales (KG) by Application (2021–2026)
 Table 61. Global Mumps Virus Vaccine Live Sales (KG) by Application (2027–2032)
 Table 62. Global Mumps Virus Vaccine Live Sales Market Share by Application (2021–2026)
 Table 63. Global Mumps Virus Vaccine Live Sales Market Share by Application (2027–2032)
 Table 64. Global Mumps Virus Vaccine Live Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Mumps Virus Vaccine Live Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Mumps Virus Vaccine Live Revenue Market Share by Application (2021–2026)
 Table 67. Global Mumps Virus Vaccine Live Revenue Market Share by Application (2027–2032)
 Table 68. Global Mumps Virus Vaccine Live Price (US$/G) by Application (2021–2026)
 Table 69. Global Mumps Virus Vaccine Live Price (US$/G) by Application (2027–2032)
 Table 70. Merck Company Information
 Table 71. Merck Description and Business Overview
 Table 72. Merck Mumps Virus Vaccine Live Sales (KG), Revenue (US$ Million), Price (US$/G), and Gross Margin (2021–2026)
 Table 73. Merck Mumps Virus Vaccine Live Product
 Table 74. Merck Recent Developments/Updates
 Table 75. GSK Company Information
 Table 76. GSK Description and Business Overview
 Table 77. GSK Mumps Virus Vaccine Live Sales (KG), Revenue (US$ Million), Price (US$/G), and Gross Margin (2021–2026)
 Table 78. GSK Mumps Virus Vaccine Live Product
 Table 79. GSK Recent Developments/Updates
 Table 80. SINOVAC Company Information
 Table 81. SINOVAC Description and Business Overview
 Table 82. SINOVAC Mumps Virus Vaccine Live Sales (KG), Revenue (US$ Million), Price (US$/G), and Gross Margin (2021–2026)
 Table 83. SINOVAC Mumps Virus Vaccine Live Product
 Table 84. SINOVAC Recent Developments/Updates
 Table 85. AIM Vaccine Company Information
 Table 86. AIM Vaccine Description and Business Overview
 Table 87. AIM Vaccine Mumps Virus Vaccine Live Sales (KG), Revenue (US$ Million), Price (US$/G), and Gross Margin (2021–2026)
 Table 88. AIM Vaccine Mumps Virus Vaccine Live Product
 Table 89. AIM Vaccine Recent Developments/Updates
 Table 90. Shanghai Institute of Biological Products Company Information
 Table 91. Shanghai Institute of Biological Products Description and Business Overview
 Table 92. Shanghai Institute of Biological Products Mumps Virus Vaccine Live Sales (KG), Revenue (US$ Million), Price (US$/G), and Gross Margin (2021–2026)
 Table 93. Shanghai Institute of Biological Products Mumps Virus Vaccine Live Product
 Table 94. Shanghai Institute of Biological Products Recent Developments/Updates
 Table 95. Key Raw Materials Lists
 Table 96. Raw Materials Key Suppliers Lists
 Table 97. Mumps Virus Vaccine Live Distributors List
 Table 98. Mumps Virus Vaccine Live Customers List
 Table 99. Mumps Virus Vaccine Live Market Trends
 Table 100. Mumps Virus Vaccine Live Market Drivers
 Table 101. Mumps Virus Vaccine Live Market Challenges
 Table 102. Mumps Virus Vaccine Live Market Restraints
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources
 Table 106. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Mumps Virus Vaccine Live
 Figure 2. Global Mumps Virus Vaccine Live Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Mumps Virus Vaccine Live Market Share by Type: 2025 & 2032
 Figure 4. Single-dose Medication Product Picture
 Figure 5. Combination Medication Product Picture
 Figure 6. Global Mumps Virus Vaccine Live Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Mumps Virus Vaccine Live Market Share by Application: 2025 & 2032
 Figure 8. Children
 Figure 9. Adults
 Figure 10. Global Mumps Virus Vaccine Live Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 11. Global Mumps Virus Vaccine Live Market Size (US$ Million), 2021–2032
 Figure 12. Global Mumps Virus Vaccine Live Sales (KG), 2021–2032
 Figure 13. Global Mumps Virus Vaccine Live Average Price (US$/G), 2021–2032
 Figure 14. Mumps Virus Vaccine Live Report Years Considered
 Figure 15. Mumps Virus Vaccine Live Sales Share by Manufacturers in 2025
 Figure 16. Global Mumps Virus Vaccine Live Revenue Share by Manufacturers in 2025
 Figure 17. Top 5 and Top 10 Global Mumps Virus Vaccine Live Players: Market Share by Revenue in Mumps Virus Vaccine Live in 2025
 Figure 18. Mumps Virus Vaccine Live Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 19. Global Mumps Virus Vaccine Live Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 20. North America Mumps Virus Vaccine Live Sales Market Share by Country (2021–2032)
 Figure 21. North America Mumps Virus Vaccine Live Revenue Market Share by Country (2021–2032)
 Figure 22. United States Mumps Virus Vaccine Live Revenue Growth Rate (US$ Million), 2021–2032
 Figure 23. Canada Mumps Virus Vaccine Live Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Europe Mumps Virus Vaccine Live Sales Market Share by Country (2021–2032)
 Figure 25. Europe Mumps Virus Vaccine Live Revenue Market Share by Country (2021–2032)
 Figure 26. Germany Mumps Virus Vaccine Live Revenue Growth Rate (US$ Million), 2021–2032
 Figure 27. France Mumps Virus Vaccine Live Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. U.K. Mumps Virus Vaccine Live Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. Italy Mumps Virus Vaccine Live Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Russia Mumps Virus Vaccine Live Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Asia Pacific Mumps Virus Vaccine Live Sales Market Share by Region (2021–2032)
 Figure 32. Asia Pacific Mumps Virus Vaccine Live Revenue Market Share by Region (2021–2032)
 Figure 33. China Mumps Virus Vaccine Live Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Japan Mumps Virus Vaccine Live Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. South Korea Mumps Virus Vaccine Live Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. India Mumps Virus Vaccine Live Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Australia Mumps Virus Vaccine Live Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. China Taiwan Mumps Virus Vaccine Live Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Southeast Asia Mumps Virus Vaccine Live Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Latin America Mumps Virus Vaccine Live Sales Market Share by Country (2021–2032)
 Figure 41. Latin America Mumps Virus Vaccine Live Revenue Market Share by Country (2021–2032)
 Figure 42. Mexico Mumps Virus Vaccine Live Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Brazil Mumps Virus Vaccine Live Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Argentina Mumps Virus Vaccine Live Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Colombia Mumps Virus Vaccine Live Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Middle East and Africa Mumps Virus Vaccine Live Sales Market Share by Country (2021–2032)
 Figure 47. Middle East and Africa Mumps Virus Vaccine Live Revenue Market Share by Country (2021–2032)
 Figure 48. Turkey Mumps Virus Vaccine Live Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Saudi Arabia Mumps Virus Vaccine Live Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. UAE Mumps Virus Vaccine Live Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Global Sales Market Share of Mumps Virus Vaccine Live by Type (2021–2032)
 Figure 52. Global Revenue Market Share of Mumps Virus Vaccine Live by Type (2021–2032)
 Figure 53. Global Mumps Virus Vaccine Live Price (US$/G) by Type (2021–2032)
 Figure 54. Global Sales Market Share of Mumps Virus Vaccine Live by Application (2021–2032)
 Figure 55. Global Revenue Market Share of Mumps Virus Vaccine Live by Application (2021–2032)
 Figure 56. Global Mumps Virus Vaccine Live Price (US$/G) by Application (2021–2032)
 Figure 57. Mumps Virus Vaccine Live Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona